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Abstract
Background: Streptococcus suis is an emerging zoonotic pathogen and is the leading cause of bacterial meningitis
in adults in Vietnam. Systematic data on the antimicrobial susceptibility profiles of S. suis strains isolated from
human cases are lacking. We studied antimicrobial resistance and associated resistance determinants in S. suis
isolated from patients with meningitis in southern Vietnam.
Methods: S. suis strains isolated between 1997 and 2008 were investigated for their susceptibility to six
antimicrobial agents. Strains were screened for the presence and expression of tetracycline and erythromycin
resistance determinants and the association of tet(M) genes with Tn916- like transposons. The localization of
tetracycline resistance gene tet(L) was determined by pulse field gel electrophoresis and Southern blotting.
Results: We observed a significant increase in resistance to tetracycline and chloramphenicol, which was
concurrent with an increase in multi-drug resistance. In tetracycline resistance strains, we identified tet(M), tet(O), tet
(W) and tet(L) and confirmed their expression. All tet(M) genes were associated with a Tn916-like transposon. The
co-expression of tet(L) and other tetracycline resistance gene(s) encoding for ribosomal protection protein(s) was
only detected in strains with a minimum inhibitory concentration (MIC) of tetracycline of ≥ 64 mg/L
Conclusions: We demonstrated that multi-drug resistance in S. suis causing disease in humans in southern
Vietnam has increased over the 11-year period studied. We report the presence and expression of tet(L) in S. suis
strains and our data suggest that co-expression of multiple genes encoding distinct mechanism is required for an
MIC ≥ 64 mg/L to tetracycline.
Background
Streptococcus suis is an emerging zoonotic pathogen
associated with pigs and can cause severe systemic
infections in humans. Up to date approximately 800
human S. suis infections have been reported from over
twenty countries [1]. The most noticeable incident was
as i n g l eo u t b r e a ki nC h i n aa f f e c t i n g2 1 5i n d i v i d u a l s ,o f
whom 38 died [2]. S. suis serotype 2 is the most com-
mon serotype associated with human disease [3] and is
the most common cause of acute bacterial meningitis in
adults in Vietnam [1,4,5].
Antimicrobial susceptibility profiles and the corre-
sponding resistance determinants of S. suis have been
reported in strains isolated from pigs, but there are only
limited data from strains isolated from human patients
[6-12]. Resistance to tetracycline and macrolide-lincosa-
mide- streptogramin B (MLSB) has been widely reported
in S. suis strains isolated from pigs in Asia, Europe and
North America [8-10,12-15]. In contrast, resistance to
chloramphenicol is uncommon [8,14].
The gene erm(B), which encodes erythromycin riboso-
mal methylase, is associated with resistance to MLSB,
and has been identified in a large number of S. suis
strains from Hongkong and Belgium [7,9]. Tetracycline
resistance in S. suis was mainly associated with tet(M),
tet(O), tet(W) and tet(O/W/32/O); yet, efflux proteins
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any medium, provided the original work is properly cited.encoded by tet(L) and tet(K), which also determine tetra-
cyline resistance, have not been reported [7,8,10,11,15-19].
The co-existence of tet(M) and tet(O) genes in S. suis sero-
type 2 has been detected in limited number of strains iso-
lated from humans and pigs in China and Italy [7,10,11].
We have previously shown that 79/95 (83.2%) S. suis ser-
otype 2 strains isolated from adults with meningitis in
Vietnam were resistant to tetracycline, and 19/94 (20.2%)
were resistant to erythromycin [4]. We have also described
the concurrent presence of tet(L), tet(M), tet(O) and erm
(B) genes in one S. suis serotype 2 strain isolated from a
Vietnamese patient [20]. However, longitudinal data of
antimicrobial resistance over many years and the asso-
ciated resistance determinants of a large number of S. suis
strains isolated from human patients have not been
reported. Here we describe the antimicrobial resistance
pattern, trends and the genetic determinants of tetracy-
cline and erythromycin resistance in S. suis strains isolated
from adult patients with meningitis in 12 consecutive
years (1997-2008), in southern Vietnam.
Methods
Bacterial strains
All strains used in this study were obtained from samples
which were collected for diagnostic purposes as part of
standard care, at The Hospital for Tropical Diseases
(HTD) in Ho Chi Minh City, Vietnam. The study protocol
was approved by the ethical committee of the HTD (CS/
NĐ/09/13). A total of 175 non-duplicate S. suis strains,
isolated from the cerebral spinal fluid (CSF) of adult
patients with meningitis admitted to the HTD between
March 1997 and November 2008, were investigated. Bac-
terial culture, identification and serotyping of S. suis was
performed as previously described [4]. All strains, with the
exception of four strains belong to serotype 14 (n = 3) and
serotype 16 (n = 1) [21], were of serotype 2.
Antimicrobial susceptibility testing
Antimicrobial susceptibility testing was performed by
assessing the minimum inhibitory concentration (MIC)
for all isolates using E-test (AB Biodisk, Sweden)
according to the manufacturer recommendations. The
antimicrobials tested were penicillin, ceftriaxone, vanco-
mycin, chloramphenicol, erythromycin and tetracycline.
Antimicrobial resistance was assessed using breakpoints
recommended by the Clinical and Laboratory Standard
Institute (CLSI) guidelines 2008 (M100-S18). There are
currently no breakpoints recommended for S. suis,
therefore, breakpoints for viridans group Streptococci
were used (Table 1). Streptococcus pneumoniae strain
ATCC 49619 was used for quality control purpose. Ery-
thromycin resistance phenotypes were identified using
the triple disk diffusion test as described [22].
Detection of erythromycin and tetracycline resistance
determinants
Genomic DNA was extracted using DNEasy tissue kit
(Qiagen, United Kingdom). The erm(A), erm(B), mef(A),
tet(M), tet(O), tet(L) and tet(K) genes were detected by
multiplex PCR as previously described [23]. The presence
of tet(W) and mosaic gene tet(O/W/32/O) was screened
using primers as described in Table 2. DNA sequencing
of PCR amplicons was performed to confirm the pre-
sence of the full length tet(W) gene using primers tet
(W)-F, tetO-2-F, tetO-2-R and tet(W)-R (Table 2).
S. suis strain BM407, which contains the genes tet(M),
tet(O), tet(L) and erm(B), and S. suis strain BM331 con-
taining the full length tet(W) gene, were used as positive
control strains [20]. The presence of Tn916-like conju-
gative transposons was screened for in all tet(M) positive
strains by amplification of the xis-Tn gene of Tn916,a s
described elsewhere [24]. The association of the tet(M)
gene with Tn916 was demonstrated in xis-Tn and tet
(M) positive strains by an additional PCR using primers
Tn916-2 and P8-tet(M)-R (Table 2).
Detection of expression of tetracycline resistance genes
The expression of tetracycline resistance genes was deter-
mined in all S. suis strains possessing multiple tetracy-
cline resistance determinants according to techniques
Table 1 Distribution of minimal inhibitory concentrations of antimicrobial agents tested in Streptococcus suis strains
isolated from patients with meningitis
Antimicrobial Agent Minimal Inhibitory Concentrations
Breakpoint* (mg/L) Range (mg/L) MIC50
# (mg/L) MIC90
# (mg/L) Resistant strains (%)
Tetracycline S ≤ 2; R ≥ 8 0.125–>256 24 32 88.6
Erythromycin S ≤ 0.25; R ≥ 1 0.016– >256 0.064 >256 22.2
Chloramphenicol S ≤ 4; R ≥ 16 0.5-96 3 4 8.6
@
Penicillin S ≤ 0.12; R ≥ 4 0.012-0.064 0.032 0.047 0
Ceftriaxone S ≤ 0.5 0.025-0.38 0.094 0.125 0
Vancomycin S ≤ 1 0.25-0.5 0.38 0.5 0
*: Breakpoints are based on equivalent CLSI breakpoints for Streptococcus spp. viridans group
#: MIC50, MIC90 are the MIC values inhibiting growth of 50% and 90% of tested isolates, respectively.
@: Including the intermediate resistant isolates
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cline disk (30 ug) was placed on a Mueller-Hinton agar
plate inoculated with a 0.5 McFarland suspension of the
test S. suis strain. Colonies surrounding the zone of inhi-
bition were harvested for RNA extraction. cDNA was
synthesized using random hexamer primers and the sub-
sequent products were used as templates for multiplex
PCR for detection of tetracycline resistance genes tet(M),
tet(O), tet(L), and tet(K) (Table 1). RT-PCR of cps2J or
16SrRNA gene products was used as internal control.
Pulse Field Gel Electrophoresis (PFGE) and Southern blot
to detect the location of tet(L) in S. suis isolates
Agarose plugs were prepared and solidified plugs were
processed as described [25]. SmaI digested genomic
DNA was electrophoresed by PFGE in a CHEF mapper
Table 2 Primers used to amplify the tetracycline and macrolide resistance determinants and for sequencing purpose
Primer Sequence (5’ -3 ’) Product size Position in coding sequence Reference
erm(A)-F CCCGAAAAATACGCAAAATTTCAT 590 15-38 [23]
erm(A)-R CCCTGTTTACCCATTTATAAACG 604-582
erm(B)-F TGGTATTCCAAATGCGTAATG 745 203-183
erm(B)-R CTGTGGTATGGCGGGTAAGT 541-522
mef(A)-F* CAATATGGGCAGGGCAAG 317 38-55
mef(A)-R* AAGCTGTTCCAATGCTACGG 352-333
tet(M)-F GTGGACAAAGGTACAACGAG 406 106-125
tet(M)-R CGGTAAAGTTCGTCACACAC 511-492
tet(O)- F AACTTAGGCATTCTGGCTCAC 515 13-43
tet(O)- R TCCCACTGTTCCATATCGTCA 527-507
tet(K)-F GATCAATTGTAGCTTTAGGTGAAGG 155 344-368
tet(K)-R TTTTGTTGATTTACCAGGTACCATT 498-474
tet(L)-F TGGTGGAATGATAGCCCATT 229 384-403
tet(L)-R CAGGAATGACAGCACGCTAA 612-593
16S-rDNA-F GAGTACGACCGCAAGGTTGA 100 886-905
16S-rDNA -R CTGGTAAGGTTCTTCGCGTTG 985-964
ss-Tn916-1 GCCATGACCTATCTTATA 476 16083-16100 [24]
ss-Tn916-2 CTAGATTGCGTCCAA 16559-16545
tet(32)For GAACCAGATGCTGCTCTT 620 619-637 [28]
Tet(32)Rev CATAGCCACGCCCACATGAT 1239-1220
SScps2J-F CAAACGCAAGGAATTACGGTATC 236 209-231 [29,30]
SScps2J-R CATTTCCTAAGTCTCGCACC 445-426
tet(L)Ng-F TCGTTAGCGTGCTGTCATTC 698 680-700 [31]
tet(L)-R-pDG364 CTTAGAAATCCCTTTGAGAAT 1378-1358 This study
tet(W)- F TTGGAATTCTTGCCCATGTAGACGC 1872 18-42 This study
tet(W)- R TTGTCCAGGCGGTTGTTTGGAC 1889-1868
tet(W)-F-HN GGTGCAGTTGGAGGTTGTTT 410 1179-1198
tet(W)-R-HN CCTTCAATGCCTGTTCCAAT 1569-1588
tet(O)-F-pDG364 ATGAAAATAATTAACTTAGG 1920 1-19
tet(O)-R-pDG364 TTAAGCTAACTTGTGGAACA 1920-1901
ss-tet(M)-whole-F ACAGACAAAGAACTATCCTTAATG 2500 419-396
ss-tet(M)-whole-R GTACCCAGTTTAAGAATACCTTTATC 161-136
Additional primers used for sequencing
tet(O)-2-F TTCAAGACGCCTCCCTGTTC 679-698 This study
tet(O)-2-R ATTTGGCGGGACTTCTATGTGG 1318-1296
ss-tet(M)-Fseq1 GTTAAATCACTACGATAT 1763-1745
ss-tet(M)-Rseq1 ATAGTGTTCTTGGAGATA 906-929
ss-tet(M)-Fseq2 GTATAATTTCATGTGTCG 1162-1144
ss-tet(M)-Rseq2 AGATGGCGTACAAGCACA 305-323
ss-PAI-P8-tet(M)-R GCCCTTTTGGGTTTTTGAAT -33- -14
ss-PAItetM-P9over F GGGAATCCCCATTTTCCTAA 366-347
*: These primers were named mef(A/E) in the referenced publication.
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chromosomal DNA was achieved using the conditions
suitable for separation of DNA fragments between 1.2
Kb and 100 Kb. S. suis strain BM407, which was shown
previously to contain one plasmid and the tet(L) gene,
located on the chromosome, was used as positive con-
trol [20]. Ten nanograms (10 ng) of PCR amplicon tet
(L) (698 bp) was included as a positive control for
Southern blotting in each gel. DNA was transfered to
the nitrocellulose membranes using a vacuum blotter
(BioRad, Vietnam).
The probe for detection of the tet(L) gene after South-
ern blotting was prepared using the same PCR ampli-
con, which was labeled using the ECL direct nucleic
acid labeling and detection kit (GE Healthcare, HCMC,
Vietnam).
Statistical analysis
We tested for a linear time trend in differential antimi-
crobial resistance rates using logistic regression with the
antimicrobial susceptibility of the strain as the outcome
and the calendar year of the strain collection as the cov-
ariate. As only one strain was collected in 1997, it was
excluded from all statistical analyses. Strains with inter-
mediate resistance were considered resistant for the pur-
pose of these analyses. The MIC of tetracycline was
compared between tetracycline resistant S. suis groups.
Four groups of tetracycline resistant strains were defined
as follows: strains carrying tet(M); strains carrying tet
(O); strains carrying tet(M) and tet(O); and strains carry-
ing tet(M) and tet(L) or tet(M), tet(O) and tet(L). The
sole strain which contained tet(M) and tet(L) was added
to the latter group prior to the analysis. We used a
Kruskal-Wallis test for the overall comparison of the
four groups and then performed pair-wise comparisons
using Wilcoxon rank-sum tests with Holm correction
for multiple testing. All reported p-values correspond to
two-sided tests and analyses were performed with R
2.8.1 (R Foundation for Statistical Computing, Vienna,
Austria).
Results
Antimicrobial susceptibility profiles and macrolide
resistance phenotype
All 175 S. suis strains were fully susceptible to penicillin,
ceftriaxone and vancomycin (Table 1). Fourteen strains
were sensitive to all 6 antibiotics tested. A total of 159/
175 (90.9%) strains were resistant to tetracycline and 39/
175 (22.2%) strains were resistant to erythromycin. Fif-
teen (8.6%) strains were resistant to chloramphenicol,
including those demonstrating intermediate resistance
(Figure 1). The macrolide resistance phenotype was iden-
tified using triple-disk tests in 38/39 erythromycin resis-
tant strains. Of these, 37 (97.4%) strains demonstrated a
cMLSB phenotype and the remaining strain expressed the
iMLSB -A phenotype.
Resistance to tetracycline significantly increased over
time (OR = 1.77 [95% CI 1.36-2.30] per year, p < 0.001).
The proportion of S. suis strains demonstrating inter-
mediate or full resistance to tetracycline was 80.8% (61/
78 strains) in the period 1998-2003 and 99% (95/96
strains) in the period 2004-2008 (Figure 1). A significant
increase was also observed in chloramphenicol resis-
tance (OR = 1.36 [95% CI 1.05-1.76] per year, p = 0.02)
which rose from 2.5% (2/78 strains) in 1998-2003 to
13% (12/96 strains) in 2004-2008. In contrast, there was
no significant increase in erythromycin resistance
observed over 11 years (OR = 1.04 (95% CI 0.91-1.19)
per year; p = 0.56) and the proportion of erythromycin
resistant strains was the same (22%) in both periods of
time (Figure 1). Multi-drug resistance (MDR), defined as
resistance to tetracycline, erythromycin and chloramphe-
nicol, significantly increased over time (OR = 1.36 [95%
CI = 1.04-1.77] per year, p = 0.02). Two (2.5%) and 12
MDR strains (12.5%) were isolated in 1998-2003 and in
2004-2008, respectively (Figure 1).
Tetracycline and erythromycin resistance determinants
We screened for the presence of tetracycline and ery-
thromycin resistance determinants in 169 isolates,
Figure 1 Proportional distribution of antimicrobial resistant S.
suis strains between 1998 and 2008. Streptoccoccus suis strains
were isolated from patients with acute bacterial meningitis admitted
to the Hospital for Tropical Diseases between 1998 and 2008. The
numbers above each column correspond to the total number of
strains isolated in each year (the lone isolate from 1997 is not
included. Diagonal, grey and white bars represent the proportion of
strains resistant to tetracycline, erythromycin and chloramphenicol,
respectively. Black bars represent the proportion of MDR strains
(resistant to tetracycline, erythromycin and chloramphenicol).
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serotype 16 strains. The tetracycline resistance determi-
nant tet(M) was successfully amplified in 129/153
(84.3%) tetracycline resistant isolates. The presence of
the xis-Tn gene of Tn916-like transposons and its asso-
ciation with tet(M) was further screened by PCRs in
strains that contained tet(M). All tet(M) positive S. suis
strains produced amplicons for both the xis-Tn gene
and the DNA fragments linking xis-Tn and tet(M)
genes. The tet(O) gene was found in 33 (21.6%) strains
and tet(L) was detected in 5 (3.3%) strains. The three
genes tet(M), tet(O) and tet(L) were concomitantly
amplified in 4 (2.6%) strains. We detected several differ-
ent combinations of tetracycline resistance genes in
individual strains. The genes tet(M) and tet(L) or tet(M)
and tet(O) were found in 6 (3.9%) isolates, whilst single
tetracycline resistance gene tet(M) or tet(O) were pre-
sent in 139 (90.8%) strains. We identified 2/92 tested
strains containing the full-length tet(W) gene.
Resistance determinant erm(B) was detected in 36/38
(94.7%) erythromycin resistant strains. All possible com-
binations of the erm(B) gene with tetracycline resistance
genes tet(M), tet (O) and tet(L) were found. We were
unable to amplify amplicons of the genes tet(K), tet(O/
W/32/O), erm(A) and mef(A) in any of the strains stu-
died. Statistical analysis showed no association between
tetracycline and erythromycin resistance of S. suis
strains (p = 0.53).
Defining the genomic location of tet(L) in S. suis
The gene tet(L) was previously found on a conjugative
element integrated into the chromosome of S. suis strain
BM407 [20]. However, tet(L) is often found on small
transmissible plasmids [26]. Using PFGE and Southern
blotting we investigated whether tet(L) genes of the
other tet(L) PCR positive S. suis strains were also
located on the chromosomes or on replicons additional
to chromosomes. Figure 2 shows hybridization patterns
for the presence of tet(L) after Southern blotting of
SmaId i g e s t e dD N Ao ff o u rS. suis strains BM308,
BM407, EN031 and EN241. Only strain BM407 was
found to contain plasmid DNA (data not shown), which
confirms a previous observation that this strain contains
a 24,579 bp-pBM407 plasmid with unknown function
[20]. Southern hybridization confirmed the location of
tet(L) on fragments between 398 and 668 Kb in size on
the chromosomes of studied strains.
Expression of tetracycline resistance determinants
The MICs of tetracycline differed significantly between
the 4 groups of strains containing tetracycline resistance
genes (p < 0.001, Kruskal-Wallis test). Pair-wise compar-
isons revealed that the MICs to tetracycline for strains
containing tet(M) and tet(L) or tet(M), tet(O) and tet(L)
genes was higher than for strains possessing both tet(M)
and tet(O) genes, and for strains containing only tet(M)
or tet(O) (Table 3).
Among the four S. suis strains (BM308, BM407,
EN031 and EN241) that possessed the three tetracycline
resistance genes tet(M), tet(O), and tet(L), only strain
Figure 2 Chromosomal location of tet(L) genes in S. suis
isolates. (A1, B1) PFGE patterns of SmaI digested genomic DNA of
four S. suis serotype 2 strains, (A2, B2): Southern blot hybridization of
SmaI digested genomic DNA of four strains with 698 bp- tet(L)
probe. (A) Lane 1: S. suis BM308; lane 2: S. suis BM407; (B) lane 1: S.
suis EN031; lane 2: S. suis EN241. (A, B) Lane 3: 698 bp-tet(L) PCR
amplicons, which was added to the well of PFGE gel one hour prior
to completion of the PFGE running programme. Molecular weights
of marker bands, consisting of XbaI digested genomic DNA of
Salmonella serotype Braenderup strain (H9812), spanning the region
containing the positive signals of tet(L), are indicated.
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MIC was 64 mg/L for the other three strains. We
attempted to confirm the co-transcription of the three
tetracycline resistance determinants in these four strains.
The transcription of all 3 genes simultaneously was only
detected in strain BM407. We could not detect the
expression of tet(M) in one strain and mRNA from tet
(O) was not detected in the other two strains (data not
shown). However, we detected the presence of mRNAs
from tet(M) and tet(L) in the single strain which con-
tained both these determinants, which had a MIC of 64
mg/L to tetracycline.
Discussion
Invasive human infections by S. suis are becoming
increasingly reported in Asia. We have observed an
increase in the number of infections caused by S. suis
serotype 2 at the Hospital for Tropical Diseases in
HCMC since 1998. This increase could be due to
increased awareness and/or a true increase in the inci-
dence of disease. Here we have shown an increase in a
tetracycline and chloramphenicol resistance over an ele-
ven- year period. This suggests that continuous surveil-
lance for antimicrobial resistance in S. suis is important
to guide current and future treatment of human and
porcine disease caused by S. suis.
Our data show that all S. suis strains isolated from
adult patients over a twelve year period in Vietnam
were sensitive to penicillin. Whilst S. suis resistant to
penicillin has been reported in isolates from pigs in
Denmark, Poland and Portugal [8], it does not appear to
be emerging in Vietnam.
We did, however, demonstrate a high proportion of tet-
racycline resistance (91%). Tetracycline resistance has been
reported previously in S. suis isolated from pig in various
location in Asia and Europe [7,10-12]. Since S. suis infec-
tion in human is associated with exposure to pigs or con-
taminated pork [1], the increase in tetracycline resistance
in strains isolated from humans may be related to tetracy-
cline usage in animal production for prophylaxis or therapy
leading to positive selection of resistant strains. Although
data on antimicrobial drug use in animal husbandry in
Vietnam is currently unavailable, we observed a tetracy-
cline resistance rate of 100% in 45 S. suis serotype 2 strains
isolated from a representative sample of healthy slaughter-
house pigs in southern Vietnam in 2006 and 2007, suggest-
ing that current tetracycline resistance rates in pig carriage
strains are extremely high (Hoa et al, in preparation).
Resistance to tetracycline was encoded by multiple
determinants including tet(L) in this strain collection.
We were able to demonstrate that the tet(L) gene was
located on the chromosomes of four strains and the tet
(L) transcription was detected in all five S. suis strains
with tet(L) amplicons positive. The presence of the gene
tet(L) has, until now, only been described in the genome
sequence of S. suis serotype 2 strain BM407, which was
isolated from a patient with meningitis in Vietnam [20].
The most frequently identified tetracycline resistance
gene was tet(M) and its association with the presence of
Tn916 like elements was confirmed in all tet(M) positive
strains. Mobile genetic elements, including transposons
and integrative elements, are common in Streptococci
such as S. suis [11]. The colonization of S. suis in the
upper respiratory and gastrointestinal tracts of healthy
pigs is well known, and the transfer of mobile DNA in
such locations is common [20].
In our study, strains carrying multiple tetracycline
resistance genes were likely to associate with higher
MIC to tetracycline than those carrying single or two
resistance genes. The difference in MIC to tetracycline
in four strains, all harbouring tet(M), tet(O), and tet(L),
was likely due to the simultaneous expression of these
genes. The proteins encoded by tet(M) and tet(O) pre-
vent tetracycline binding to its target on the bacterial
ribosome, whilst tet(L) encodes a membrane-associated
protein, which facilitates tetracycline export from the
Table 3 Groups of S. suis strains with different combinations of tetracycline genes and respective minimal inhibitory
concentrations
Number of isolates Group Tetracycline resistance genes MIC50* (mg/L) Range of MIC (mg/L) p-values
#
51 tet(M), tet(O) and tet(L) or tet(M) and tet(L) 64 64 - 256 0.01 (group 1 vs. 2)
<0.001 (group 1 vs. 3)
0.002 (group 1 vs. 4)
0.002 (group 2 vs. 3)
0.03 (group 2 vs. 4)
0.08 (group 3 vs. 4)
82 tet(M) and tet(O) 32 24 - 48
116 3 tet(M) 24 3 - 48
22 4 tet(O) 24 16 - 32
* MIC50 is the MIC value inhibiting growth of 50% of tested isolates
# Pair-wise comparisons based on Wilcoxon rank-sum tests with Holm correction for multiple testing
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of tetracycline resistance genes encoding for efflux pro-
tein and ribosomal protection proteins in the same S.
suis strain results in an elevated MIC to tetracycline.
Erythromycin resistance has been reported in S. suis
strains isolated from human infections in Hong Kong,
with a proportion of resistant strains similar to that
observed in our study (21.2%) [7]. The proportions of
resistance to erythromycin of S. suis strains isolated
from pig are higher in other countries including Den-
mark (29.1%), the United Kingdom (36%), the Nether-
lands (35%) and Poland (30.6%), France (64.6%), China
(67.2%), Portugal (75%) and Italy (78%) [8,10,12]. We
were unable to amplify target sequences for the genes
erm(A), erm(B) and mef(A) in two erythromycin resis-
tant strains. These data suggest that other erythromycin
resistance determinants may be present in S. suis and
requires additional investigations.
The usage of chloramphenicol in agriculture has been
banned in Vietnam since 2003. However, other amphe-
nicols (such as florfenicol) are still allowed to use in
agriculture and animal husbandry in Vietnam. The
increasing proportion of chloramphenicol resistant S.
suis strains isolated from humans in Vietnam may be
associated with other amphenicols use. It is also possible
that the chloramphenicol resistance determinants are
under co-selection in strains that are resistant to other
antimicrobials currently approved for veterinary use in
the prevention and treatment of infections, such as tet-
racyclines and macrolides. It is noteworthy that all
chloramphenicol resistant strains in our study were
additionally resistant to tetracycline or erythromycin or
both. The genome sequence publication of S. suis strain
BM407 described that the resistance determinants erm
(B), tet(O), cat, tet(L) and tet(M) are all located within a
40 Kb DNA region of a conjugative mobile element in
this strain [20]. This would support the hypothesis of
co-selection of antimicrobial resistance determinants.
Conclusion
This study reported an increasing proportion of antimi-
crobial resistant S. suis isolates from adult patients with
meningitis in southern Vietnam over 11 consecutive
years. We demonstrated the presence and expression of
tet(L) gene in S. suis. Our results imply that the simulta-
neous expression of the tet(L) gene and additional tetra-
cycline resistance gene(s), encoding for the ribosomal
protection protein(s), in S. suis is associated with higher
MIC to tetracycline.
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